CLOSE

Dialog Box

Loading...

 

About

 

Maddie Riewoldt’s Vision (Maddie’s Vision) is dedicated to finding a cure for bone marrow failure syndromes. Since inception in 2015, Maddie’s Vision has been a galvanizing force in elevating awareness of bone marrow failure, raising substantial funds (over $7 million AUD in committed funds) and purposefully identifying and supporting the best researchers in Australia, enabling them to specifically undertake focused research in Bone Marrow Failure.

In 2018, with assistance from State Government funding, Maddie’s Vision established the Centre of Research Excellence in Bone Marrow Biology. The CRE has provided a centralised contact point for all current grantees, researchers and co-researchers, community organisations and commercial entities.

 
*Victorian Comprehensive Cancer Centre building: Photography by Peter Bennets, courtesy Plenary Health 

Encompassing the 5 Pillars of Research of Maddie Riewoldt’s Vision, the CRE has provided capacity to incorporate additional projects, to complete a critical mass of researchers and complementary projects, to expand infrastructure and coordinate BMFS research opportunities. The CRE has generated a synchronisation of current and future research opportunities, and is amplifying and accelerating research outcomes.

The CRE is delighted to present Australia’s Inaugural National Symposium on Bone Marrow Failure Syndromes which will take place across two days in May 2019 at the Victorian Comprehensive Cancer Centre, Melbourne. The scientific symposium will explore both clinical and research aspects of Bone Marrow Biology, acquired and inherited Bone Marrow Failure Syndromes.

 
*Victorian Comprehensive Cancer Centre building: Photography by Peter Bennets, courtesy Plenary Health 

It will provide an opportunity to bring together the most innovative, talented and exceptional minds in the field of Bone Marrow Failure Syndromes Australia wide. We are thrilled to welcome two international guest speakers - Dr Akiko Shimamura, Professor of Paediatrics Harvard Medical School, and Director BMF and MDS Program Dana Farber Boston Children’s Cancer and Blood Disorder Centre, and Dr Austin Kulasekararaj of King’s College Hospital NHS Foundation Trust, London, who together will bring exceptional expertise from both a paediatric and adult perspective.

Dr Austin Kulasekararaj is visiting Melbourne as an Expert-in-Residence of Melbourne Genomics Health Alliance.